FUNCTION OF AN INTERFERON-INDUCED UBIQUITION HOMOLOG
干扰素诱导的泛在同系物的功能
基本信息
- 批准号:3306922
- 负责人:
- 金额:$ 18.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-04-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis antisense nucleic acid autoradiography chemical conjugate chemical stability circular dichroism covalent bond crystallization cycloheximide enzyme mechanism gene induction /repression genetic library immunocytochemistry interferons isotope dilution method laboratory rabbit molecular cloning posttranslational modifications protein biosynthesis protein degradation protein purification protein structure function stable isotope double label tissue /cell culture ubiquitin western blottings
项目摘要
In responsive cells, type I and type II interferons induce 15-20
different proteins that are thought to mediate the host of cellular
regulatory effects such as changes in cell structure, activity,
differentiation, proliferative capacity, presentation of major
histocompatibility antigens, and anti-viral activity. However, the
functions for few of these proteins have been ascribed to date, although
such knowledge is fundamental to understanding and exploiting the
potential of the interferons as therapeutic agents. One such
interferon-induced protein of unknown function has a molecular weight of
15 kDa. This protein must be important for the ability of cells to mount
an interferon response since it is rapidly induced and its accumulation
parallels the appearance of antiviral activity. We have previously
proposed that this polypeptide, termed Ubiquitin Cross-Reactive Protein
(UCRP) because of its immunological and sequence similarity to ubiquitin,
represents a function-specific homolog of ubiquitin. More recently we
have shown that, like ubiquitin, UCRP is subject to both constitutive and
interferon-induced covalent conjugation to a spectrum of intracellular
proteins. The long-term objectives of this proposal are to understand
the role of UCRP conjugation in normal cellular regulation and in
response to interferon. The specific aims of the proposal are: (1) to
physically characterize recombinant UCRP stability by CD measurements and
to crystallize the protein for subsequent structure determination; (2) to
examine the dynamics of intracellular pools of free and conjugated UCRP
in normal and interferon-induced cells using affinity-purified polyclonal
antibodies against UCRP in conjunction with pulse-chase studies and
inhibition of UCRP induction with specific antisense oligonucleotide
probes; (3) to study the conjugation of UCRP to cytoskeletal proteins
using the anti-UCRP antibodies as immunohistochemical probes for
localization of the adducts; (4) to characterize the enzymological steps
in UCRP conjugation and isolate by affinity and FPLC methods the
enzyme(s) responsible for this unique post-translational modification;
and (5) to clone, sequence, and expressed recombinant UCRP conjugating
enzyme(s) using current molecular biological techniques. The resulting
characteristics of the UCRP conjugating system will be compared to the
parallel but distinct ubiquitin ligation pathway.
在反应性细胞中,I 型和 II 型干扰素诱导 15-20
不同的蛋白质被认为介导宿主细胞
调节作用,例如细胞结构、活性的变化,
分化、增殖能力、主要表现
组织相容性抗原和抗病毒活性。 然而,
迄今为止,这些蛋白质中很少有功能已被确定,尽管
这些知识对于理解和利用
干扰素作为治疗剂的潜力。 这样的一位
干扰素诱导的未知功能蛋白的分子量为
15 kDa。 这种蛋白质对于细胞的安装能力一定很重要
干扰素反应,因为它被快速诱导并积累
与抗病毒活性的出现相似。 我们之前有过
提出这种多肽,称为泛素交叉反应蛋白
(UCRP) 由于其免疫学和序列与泛素相似,
代表泛素的功能特异性同系物。 最近我们
已经表明,像泛素一样,UCRP 受到本构性和
干扰素诱导的与一系列细胞内共价结合
蛋白质。 该提案的长期目标是了解
UCRP 缀合在正常细胞调节和
对干扰素的反应。 该提案的具体目标是:(1)
通过 CD 测量来物理表征重组 UCRP 稳定性
使蛋白质结晶以进行后续结构测定; (2) 至
检查细胞内游离和结合 UCRP 池的动态
使用亲和纯化的多克隆在正常和干扰素诱导的细胞中
抗 UCRP 抗体与脉冲追踪研究相结合,
用特异性反义寡核苷酸抑制 UCRP 诱导
探针; (3)研究UCRP与细胞骨架蛋白的缀合
使用抗 UCRP 抗体作为免疫组织化学探针
加合物的定位; (4) 表征酶学步骤
在 UCRP 缀合和通过亲和力和 FPLC 方法分离中
负责这种独特翻译后修饰的酶;
(5) 克隆、测序和表达重组 UCRP 缀合
使用当前分子生物学技术的酶。 由此产生的
UCRP 缀合系统的特性将与
平行但不同的泛素连接途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR L HAAS其他文献
ARTHUR L HAAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR L HAAS', 18)}}的其他基金
ABI 3100 Genetic Analyzer for Nucleic Acid Sequencing
用于核酸测序的 ABI 3100 基因分析仪
- 批准号:
6578668 - 财政年份:2003
- 资助金额:
$ 18.42万 - 项目类别:
FASEB CONFERENCE ON UBIQUITIN AND PROTEIN DEGRADATION
FASEB 泛素和蛋白质降解会议
- 批准号:
2024156 - 财政年份:1997
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6519488 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2184840 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6202892 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2184841 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6386298 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
6920554 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2392167 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
FUNCTION OF AN INTERFERON INDUCED UBIQUITIN HOMOLOG
干扰素诱导的泛素同系物的功能
- 批准号:
2684995 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 18.42万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)














{{item.name}}会员




